Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and biomanufacturing capabilities, Recombinant DNase I (RNase-free) is currently ...

DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Many arthropods perform hematophagy on vertebrate animals to obtain blood that will assist in their reproductive cycle. Therefore, pathogens use this activity to be transmitted to different hosts ...

Re “America Is Losing Its Pull for Best Minds in Science” (front page, June 4): There is another dimension by which the best minds are leaving science, particularly basic research. For years, about ...

One of the greatest transformations in modern medicine arguably began with a corned beef sandwich. It was the late 1960s, and new Department of Medicine Chair Lloyd Hollingsworth “Holly” Smith Jr., MD ...

With biopharmaceutical applications dating back to the development of recombinant-DNA technology in the late 1970s, Escherichia coli is the industry’s most extensively characterized protein-expression ...

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

Electrochemical sensing, a cornerstone of applied analytical chemistry, has witnessed significant advancements over the past 40 years. The last two decades have seen a surge in innovative developments ...

According to Nova One Advisor, the global recombinant proteins market size was estimated at USD 3.25 billion in 2024 and is expected to hit around USD 8.66 billion by 2034, poised to grow at a CAGR of ...